日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines

Itolizumab 可调节效应细胞上的激活和抑制信号,从而增强其对 CD318+ 肿瘤细胞系的细胞毒性。

Cynthia González Muñoz ,Rydell Álvarez Arzola ,Adanays Calvo Pérez ,Milagro de la Caridad Frometa Campanón ,Patricia Hernández Casaña ,Aymé Fernández-Calienes Valdés ,Patricia Lorenzo-Luaces ,Zaima Mazorra Herrera ,Tania Crombet Ramos ,Mayrel Labrada Mon

Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine: Immune Correlates in Long-Term Survivors

使用抗独特型NeuGcGM3疫苗治疗晚期非小细胞肺癌患者:长期生存者的免疫相关性

Zaima Mazorra ,Haslen H Cáceres-Lavernia ,Elia Nenínger-Vinageras ,Leslie M Varona-Rodríguez ,Carmen Elena Viada ,Zuyen González ,Nely Rodríguez-Zhurbenko ,Anne-Christine Thierry ,Gisela María Suarez-Formigo ,Yendry Ventura-Carmenate ,Petra Baumgaertner ,Sara Trabanelli ,Camila Jandus ,Tania Crombet

Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer

晚期肺癌患者细胞因子、EGF 和淋巴细胞亚群之间的关联

Gisela María Suárez #, Ana Laura Añé-Kourí #, Amnely González, Patricia Lorenzo-Luaces, Elia Neninger, Eva Elena Salomón, Leamnet Cordero, Mauricio Catalá, Nuris Ledón, Karla Pereira, Malkon Guillermo Sánchez, Beatriz García, Tania Crombet, Zaima Mazorra, Danay Saavedra, Agustin Lage

Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19

人源化抗 CD6 单克隆抗体(伊托珠单抗)在中度 COVID-19 老年患者中的应用

Yayquier Díaz, Mayra Ramos-Suzarte, Yordanis Martín, Néstor Antonio Calderón, William Santiago, Orlando Viñet, Yulieski La O, Jorge Pérez Augusto Oyarzábal, Yoan Pérez, Geidy Lorenzo, Meylan Cepeda, Danay Saavedra, Zaima Mazorra, Daymys Estevez, Patricia Lorenzo-Luaces, Carmen Valenzuela, Armando Ca

Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule

抗 EGF 抗体作为采用优化 CIMAvax-EGF 疫苗接种计划治疗的 IIIB/IV 期非小细胞肺癌患者临床疗效的替代生物标志物

Xitlally Popa, Beatriz García, Karla P Fuentes, Vivian Huerta, Karen Alvarez, Carmen E Viada, Elia Neninger, Pedro C Rodríguez, Zuyen González, Amnely González, Tania Crombet, Zaima Mazorra

Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients

一项针对晚期非小细胞肺癌患者的新型两种治疗性疫苗联合疗法的试点研究

Herrera, Zaima Mazorra; Ramos, Tania Crombet

Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine

抗表皮生长因子抗体有效抑制表皮生长因子/表皮生长因子受体结合与接受表皮生长因子癌症疫苗治疗的晚期非小细胞肺癌患者的更好生存有关

Beatriz García, Elia Neninger, Ana de la Torre, Idrissa Leonard, Rocío Martínez, Carmen Viada, Gisela González, Zaima Mazorra, Agustín Lage, Tania Crombet

Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8(+) T cells-mediated protection against melanoma B16 challenge

用 GM3 神经节苷脂纳米颗粒疫苗进行免疫可产生效应 CD8(+) T 细胞介导的针对黑色素瘤 B16 攻击的保护作用

Zaima Mazorra, Circe Mesa, Audry Fernández, Luis E Fernández